Bruceine D (4) was able to inhibit the proliferation, promote apoptosis of HCC cells and enhance the inhibitory efficacy of sorafenib in HCC via downregulating the expression of β-catenin and jagged 1 (Cheng et al., 2017). Here, JAG1 is linked to hepatocellular carcinoma.